Show simple item record

dc.contributor.authorAcha-Sagredo, A
dc.contributor.authorGanguli, P
dc.contributor.authorCiccarelli, FD
dc.date.accessioned2024-01-08T09:43:39Z
dc.date.available2022-09-10
dc.date.available2024-01-08T09:43:39Z
dc.date.issued2022-09-23
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/93496
dc.description.abstractBACKGROUND: Seemingly normal tissues progressively become populated by mutant clones over time. Most of these clones bear mutations in well-known cancer genes but only rarely do they transform into cancer. This poses questions on what triggers cancer initiation and what implications somatic variation has for cancer early detection. DESIGN: We analyzed recent mutational screens of healthy and cancer-free diseased tissues to compare somatic drivers and the causes of somatic variation across tissues. We then reviewed the mechanisms of clonal expansion and their relationships with age and diseases other than cancer. We finally discussed the relevance of somatic variation for cancer initiation and how it can help or hinder cancer detection and prevention. RESULTS: The extent of somatic variation is highly variable across tissues and depends on intrinsic features, such as tissue architecture and turnover, as well as the exposure to endogenous and exogenous insults. Most somatic mutations driving clonal expansion are tissue-specific and inactivate tumor suppressor genes involved in chromatin modification and cell growth signaling. Some of these genes are more frequently mutated in normal tissues than cancer, indicating a context-dependent cancer-promoting or -protective role. Mutant clones can persist over a long time or disappear rapidly, suggesting that their fitness depends on the dynamic equilibrium with the environment. The disruption of this equilibrium is likely responsible for their transformation into malignant clones and knowing what triggers this process is key for cancer prevention and early detection. Somatic variation should be considered in liquid biopsy, where it may contribute cancer-independent mutations, and in the identification of cancer drivers, since not all mutated genes favoring clonal expansion also drive tumorigenesis. CONCLUSION: Somatic variation and the factors governing homeostasis of normal tissues should be taken into account when devising strategies for cancer prevention and early detection.en_US
dc.format.extent1239 - 1249
dc.languageeng
dc.publisherElsevieren_US
dc.relation.ispartofAnn Oncol
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectcancer early detectionen_US
dc.subjectcancer initiationen_US
dc.subjectclone selectionen_US
dc.subjectdriver geneen_US
dc.subjecthealthy tissuesen_US
dc.subjectsomatic evolutionen_US
dc.subjectHumansen_US
dc.subjectEarly Detection of Canceren_US
dc.subjectMutationen_US
dc.subjectNeoplasmsen_US
dc.subjectClone Cellsen_US
dc.subjectCell Transformation, Neoplasticen_US
dc.titleSomatic variation in normal tissues: friend or foe of cancer early detection?en_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.annonc.2022.09.156
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/36162751en_US
pubs.issue12en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume33en_US
dcterms.dateAccepted2022-09-10
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States